Board of Directors

Board Member Gilla Kaplan, Ph.D. is the Chief Executive Officer of Gilrose Therapeutics and a Senior Advisor of Medicine Development for Global Health. Before Gilrose, Dr. Kaplan was Senior...

Board Member Isan Chen, M.D. is the Chief Executive Officer at MBrace Therapeutics. Dr. Chen is board certified in internal medicine, hematology, and medical oncology with more than 20 years of...

Board Member Jake Simson, Ph.D. is a Partner at RA Capital Management, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life science companies developing...

Board Member Melissa McCracken, Ph.D., is a Principal at Nextech Invest Ltd., where she manages investments in companies pursuing emerging cancer therapies. Dr. McCracken currently serves as a...

Nina Kjellson is a General Partner at Canaan. Nina invests in biopharma and digital health companies that serve unmet therapeutic and access needs. As a leader of Canaan’s Women of Venture...

Board Member Rehan Verjee served as President of EMD Serono and Global Head of the Innovative Medicine Franchises for Merck KGaA until March 2021. At Merck KGaA Rehan led the North American...

Board Member Robert More is a Managing Director at Alta Partners, a healthcare focused venture capital firm. Bob currently manages investments in and serves on the board of Affinivax, eGenesis,...

Board Member Siddarth Subramony, Ph.D. is Vice President for Boxer Capital, where he is responsible for conducting due diligence of public and private investments in healthcare. Prior to joining...

Chief Executive Officer Todd Harris is Chief Executive Officer of Tyra which he co-founded in August 2018. Prior to co-founding Tyra, Todd co-founded Sienna Biopharmaceuticals, Inc. (SNNA) a...